This includes HSV-1, the type most commonly linked to cold sores, and HSV-2, the type mainly associated with genital herpes. The test doesn't detect the virus itself but instead detects ...

He wondered whether a reagent was to blame, in particular the antibodies that scientists used to measure the amount of the protein and track its position in the cell. So, he and his colleagues ...

African American children with anti-AQP4 antibody-positive NMOSD had a significantly higher Expanded Disability Status Scale (EDSS) compared to non-Hispanic White children. There are racial, ethnic, ...

The company aims to supercharge antibody treatments using specially designed protein “cages” that multiply their effects, opening up new opportunities in drug development. The company was spun ...

The CHMP has backed the drug in patients aged 12 or more with NMOSD that tests positive for aquaporin-4 (AQP4) antibodies, a biomarker seen in around 80% of NMOSD cases. Enspryng was approved for ...

Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi 465-8603, Japan Exploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural ...

About clesrovimab (MK-1654) Clesrovimab (MK-1654) is an investigational, extended half-life monoclonal antibody (mAb) developed as a passive immunization for the prevention of RSV. Clesrovimab is ...

Interestingly, several clinical observations have been reported in which patients with myasthenia gravis (MG) also suffer from auto-AQP4-antibody positive NMO simultaneously. [50–56] Thus ...

The proportion of patients with poor quality of life was not significantly different between those with MOGAD and those with anti-AQP4 antibody-positive NMOSD. The overall quality of life of patients ...